Grant Avenue Capital Bolsters Investment Team with Addition of Brian Berkin
Seasoned Healthcare Private Equity Professional Joins as Managing Director
NEW YORK – October 27, 2022 – Grant Avenue Capital, LLC (“Grant Avenue” or the “Firm”), a lower middle market healthcare-focused private equity firm, today announced that Brian Berkin has joined the Firm as a Managing Director, effective immediately. In this role, Mr. Berkin will be responsible for sourcing and executing investments across Grant Avenue’s subsectors of focus, including Services, Devices, Pharma & Pharma Services, and HCIT.
A seasoned private equity professional with nearly 20 years of experience transacting across middle market healthcare, Mr. Berkin brings significant origination, due diligence, capital raising, and operations experience to Grant Avenue. Throughout the course of his career, he has worked hand-in-glove with management teams to successfully grow their businesses. At Grant Avenue, Mr. Berkin will leverage these skills to help implement the Firm’s portfolio company growth playbook which is based on six core tenets including human capital, operational efficiency, tech enablement, strategic sales and marketing, service or product line expansion, and M&A and de novos.
“Brian is an excellent addition to the Grant Avenue team, as we continue to strategically scale our platform with extraordinary talent,” said Buddy Gumina, Founder and Managing Partner of Grant Avenue. “Since our founding, we have been committed to executing on our mission of investing in and actively building world-class companies that enhance patient health, improve the overall healthcare system, and positively impact communities. I am confident that Brian, who has a proven track record of healthcare investing, deep industry relationships and high integrity, will have a strong impact on Grant Avenue, our portfolio, and our investors for years to come.”
“Grant Avenue is an experienced team of investors who have a passion for backing healthcare companies with solutions that benefit patients and drive long-term company growth,” added Mr. Berkin. “As I step into my new role, "I am excited about the significant opportunities that exist in lower middle market healthcare private equity, where I can work with Buddy and the entire Grant Avenue team to apply our thematic approach and growth playbook to build outstanding healthcare enterprises.”
Prior to joining Grant Avenue, Mr. Berkin was a Partner at Tailwind Capital where he coordinated all aspects of the investment process, including developing investment theses, identifying investment talent, managing diligence, structuring transactions, and negotiating term sheets. Previously, he held roles at Chicago Pacific Founders, LLR Partners, and Roundtable Healthcare Partners. Mr. Berkin began his career in investment banking, serving as an analyst at Credit Suisse Group and Bear, Stearns & Co. Inc. He earned a B.A. from the University of Michigan and a Master of Business Administration from The Wharton School at the University of Pennsylvania.
About Grant Avenue Capital
Founded in 2019, Grant Avenue Capital is a healthcare-focused private equity firm investing alongside forward-thinking management teams seeking an experienced and innovative investor with operational insight and flexible growth capital. Based on underlying sector trends, the Firm pursues opportunities in the lower middle market, with a focus on companies with approximately $5 million to $25 million of EBITDA across healthcare sub-sectors, including Services, Devices, Pharma & Pharma Services and HCIT. The Firm focuses on control buyouts, buy-and-builds, corporate carve-outs, joint-control partnership investments, and special situations. In addition, the Grant Avenue Foundation supports employees and portfolio companies of Grant Avenue Capital that are actively engaged with healthcare-oriented charitable organizations. For more information, please visit https://grantave.com/.
